Ainos Financials
AIMD Stock | USD 0.48 0.02 4.35% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.97 | 1.85 |
|
|
Investors should never underestimate Ainos' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Ainos' cash flow, debt, and profitability to make informed and accurate decisions about investing in Ainos Inc.
Net Income |
|
Ainos | Select Account or Indicator |
Understanding current and past Ainos Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ainos' financial statements are interrelated, with each one affecting the others. For example, an increase in Ainos' assets may result in an increase in income on the income statement.
Please note, the presentation of Ainos' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ainos' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ainos' management manipulating its earnings.
Ainos Stock Summary
Ainos competes with Tenon Medical, STRATA Skin, Neuropace, Movano, and Orthopediatrics Corp. Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US00902F1057 |
CUSIP | 00902F303 00902F204 02301P205 00902F105 |
Location | California; U.S.A |
Business Address | 8880 Rio San |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.ainos.com |
Phone | 858 869 2986 |
Currency | USD - US Dollar |
Ainos Key Financial Ratios
Return On Equity | -0.71 | ||||
Operating Margin | (359.85) % | ||||
Price To Sales | 162.46 X | ||||
Revenue | 122.11 K | ||||
Gross Profit | 410.38 K |
Ainos Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 596.6K | 260.3K | 40.8M | 37.1M | 31.8M | 33.4M | |
Other Current Liab | 100K | 145.6K | 27.0M | 1.2M | 1.2M | 1.7M | |
Net Debt | 35.5K | 930.8K | 1.9M | (584.7K) | 4.1M | 4.3M | |
Retained Earnings | (4.8M) | (6.2M) | (10.1M) | (24.1M) | (37.9M) | (36.0M) | |
Accounts Payable | 115.3K | 208.7K | 145.6K | 1.0M | 904.4K | 949.6K | |
Cash | 409.0K | 22.2K | 1.8M | 1.9M | 1.9M | 2.0M | |
Total Liab | 753.3K | 1.1M | 30.6M | 2.5M | 7.4M | 4.1M | |
Total Current Assets | 445.3K | 76.4K | 2.2M | 2.8M | 2.5M | 2.6M | |
Intangible Assets | 146.3K | 180.6K | 37.3M | 32.8M | 28.3M | 29.7M | |
Other Current Assets | 32.1K | 51.1K | 466.2K | 195.8K | 419.5K | 440.5K | |
Common Stock | 405.2K | 420.7K | 1.4M | 200.1K | 46.8K | 44.4K | |
Inventory | 0.0 | 4.1K | 3.0K | 595.2K | 167.6K | 96.3K | |
Short Term Debt | 444.6K | 953.0K | 3.6M | 1.3M | 42K | 39.9K | |
Net Tangible Assets | 583.6K | (302.9K) | (1.0M) | (27.1M) | (24.4M) | (23.2M) | |
Net Invested Capital | 287.9K | 114.7K | 39.8M | 35.9M | 30.4M | 17.1M | |
Short Long Term Debt | 444.6K | 953.0K | 29.6M | 1.3M | 42K | 39.9K | |
Net Working Capital | (308.0K) | (1.0M) | (28.4M) | 373.0K | 1.1M | 1.2M | |
Capital Stock | 405.2K | 420.7K | 1.4M | 200.1K | 46.8K | 44.4K |
Ainos Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 885.0 | 10.2K | 18.7K | 53.5K | 144.2K | 151.4K | |
Total Revenue | 11.7K | 16.6K | 594.6K | 3.5M | 122.1K | 116.0K | |
Gross Profit | 3.0K | 5.3K | 410.4K | 1.4M | (253.7K) | (241.0K) | |
Operating Income | (1.6M) | (1.4M) | (3.9M) | (14.0M) | (13.2M) | (12.5M) | |
Ebit | (1.6M) | (1.4M) | (3.9M) | (14.0M) | (13.6M) | (13.0M) | |
Ebitda | (1.6M) | (1.4M) | (1.8M) | (9.1M) | (8.8M) | (8.3M) | |
Income Before Tax | (1.6M) | (1.5M) | (3.9M) | (14.0M) | (13.8M) | (13.1M) | |
Net Income | (1.6M) | (1.5M) | (3.9M) | (14.0M) | (13.8M) | (13.1M) | |
Research Development | 52.5K | 389.0 | 1.9M | 6.8M | 7.3M | 7.7M | |
Cost Of Revenue | 8.8K | 11.3K | 184.2K | 2.1M | 375.8K | 394.6K | |
Net Interest Income | (885.0) | (10.2K) | (18.7K) | (53.5K) | (102.1K) | (97.0K) |
Ainos Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (867.6K) | (386.8K) | 1.7M | 101.9K | 32.3K | 49.1K | |
Free Cash Flow | (922.6K) | (506.8K) | (1.4M) | (3.7M) | (4.8M) | (4.5M) | |
Other Non Cash Items | 395.0K | 374.3K | 2.2K | 16.9M | 2.9M | 3.0M | |
Capital Expenditures | 13.1K | 7.2K | 143.8K | 633.8K | 93.0K | 49.8K | |
Net Income | (1.6M) | (1.5M) | (3.9M) | (14.0M) | (13.8M) | (13.1M) | |
End Period Cash Flow | 409.0K | 22.2K | 1.8M | 1.9M | 1.9M | 2.0M | |
Depreciation | 22.2K | 14.7K | 2.0M | 4.8M | 4.9M | 5.1M | |
Change To Inventory | (4.1K) | 1.1K | 3.0K | (595.2K) | 221.8K | 232.9K | |
Investments | (13.1K) | (7.2K) | (180.5K) | (630.2K) | (82.6K) | (86.8K) | |
Net Borrowings | (146.3K) | (70.1K) | 120K | 3.1M | 3.6M | 3.7M | |
Change To Netincome | 128.1K | 395.0K | 524.8K | 152.5K | 175.4K | 289.8K |
Ainos Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ainos's current stock value. Our valuation model uses many indicators to compare Ainos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ainos competition to find correlations between indicators driving Ainos's intrinsic value. More Info.Ainos Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Ainos' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ainos by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Ainos Inc Systematic Risk
Ainos' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ainos volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Ainos Inc correlated with the market. If Beta is less than 0 Ainos generally moves in the opposite direction as compared to the market. If Ainos Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ainos Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ainos is generally in the same direction as the market. If Beta > 1 Ainos moves generally in the same direction as, but more than the movement of the benchmark.
About Ainos Financials
What exactly are Ainos Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Ainos' income statement, its balance sheet, and the statement of cash flows. Potential Ainos investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Ainos investors may use each financial statement separately, they are all related. The changes in Ainos's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ainos's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in Ainos Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ainos' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ainos growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Ainos November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ainos help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ainos Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ainos Inc based on widely used predictive technical indicators. In general, we focus on analyzing Ainos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ainos's daily price indicators and compare them against related drivers.
Information Ratio | (0.08) | |||
Maximum Drawdown | 28.01 | |||
Value At Risk | (7.69) | |||
Potential Upside | 8.16 |
Complementary Tools for Ainos Stock analysis
When running Ainos' price analysis, check to measure Ainos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ainos is operating at the current time. Most of Ainos' value examination focuses on studying past and present price action to predict the probability of Ainos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ainos' price. Additionally, you may evaluate how the addition of Ainos to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies |